Cheaper Alternatives to Wegovy: What UK Pricing Actually Looks Like

What the clinical evidence tells us about the options at different price levels

NICE's appraisal of tirzepatide (TA1026, published December 2024) and its earlier recommendation for semaglutide 2.4mg (TA875) give us the clearest official comparison point. In the SURMOUNT-5 head-to-head trial, published in the New England Journal of Medicine in 2025, tirzepatide produced greater average weight reduction over 72 weeks than semaglutide 2.4mg in adults with obesity. Tirzepatide is the only dual GIP and GLP-1 receptor agonist licensed for weight management in the UK; semaglutide acts on a single pathway. Neither medicine is cheap by everyday standards, and the evidence does not point to a cheaper option that matches either on outcomes.

That matters when you're looking for a Wegovy alternative at a lower cost, because the search often starts with price and ends with a clinical question: which medicine is actually suitable for you? Orlistat, the lipase inhibitor available in lower-cost prescription and pharmacy-strength forms, operates on an entirely different mechanism (blocking fat absorption rather than reducing appetite) and carries a different side-effect profile and a different evidence base. It is a legitimate option for some people; it is not a like-for-like swap for an injectable GLP-1. The right choice depends on your health history, your BMI, any existing conditions, and what your prescriber concludes after reviewing all of that.

What headline prices on cheaper Wegovy alternatives usually leave out

Browse enough provider websites and you will spot prices that look low. It is worth asking what they actually include. A consultation fee is sometimes charged separately and only revealed at checkout. Prescription fees, dose-escalation reviews, aftercare calls when side effects appear, these are standard parts of clinically responsible prescribing, and they cost money. Some providers charge per pen at the starter dose and then reprice sharply at maintenance doses; others build delivery into the headline figure for the first month only.

None of this is a criticism of any named provider. It is a structural feature of how private medicine gets marketed. The only way to make a genuine price comparison is to ask: what is the total cost per month at the dose I am likely to reach, with everything included? That question dissolves many apparent bargains, and our guide to getting Wegovy at a fair price walks through exactly what to check before you commit.

There is also the supply-chain question. Eli Lilly raised Mounjaro's UK list price substantially from September 2025, the highest dose moved from roughly £122 to roughly £330 per four-week pen, as widely reported. Private provider prices have followed. Semaglutide pricing has moved in a similar direction, and if you are wondering whether Wegovy will get cheaper in the UK, the short answer is that the market direction over the past year has not been encouraging. Anyone offering these medicines at prices well below the current market range without a clear explanation of how is worth scrutinising carefully.

What nume charges, and why we are deliberately not the cheapest option

One honest sentence: we do not compete on price, and we never have. The single price you see on our treatment page covers your consultation, the prescription, the medicine, and free next-working-day delivery, nothing else to add at checkout, no repeat fee, no aftercare subscription. We lose the price comparison on purpose. What we are not willing to cut is the clinical review that happens before every order, the ID and live weight verification that confirms you are who you say you are, the GP notification in line with GPhC guidance, or the 7-day-a-week aftercare for when questions come up after 5pm on a Friday.

We are a GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register) and our medicines travel through the licensed UK supply chain. If you order before midday on a working day and a prescriber approves your case that day, your treatment leaves us the same afternoon and arrives with DPD the next working day. Our clinical team reviews every case personally.

If you would like to explore whether tirzepatide, rather than semaglutide, might be the more appropriate option for you (which is a clinical decision, not a price one) our Wegovy overview and the full treatment comparison are good places to start.

Why 'cheapest' is the wrong question for a prescription medicine

The MHRA has warned publicly, and repeatedly, about counterfeit weight-loss pens entering the UK through unverified online sellers. Fake pens have been found containing insulin rather than semaglutide or tirzepatide, with predictable consequences for people who injected them. In late 2025 an illicit manufacturing site producing counterfeit tirzepatide pens was raided in the UK, and enforcement that year intercepted around 20 million doses of illegally traded weight-loss medicines with an estimated street value of £45 million. These medicines are being counterfeited because demand is high and prices are high, so if you are researching how to find cheaper Wegovy, it is worth understanding exactly where that lower price is coming from before you commit. A listing that solves both problems at once should prompt a pause.

Buying from a pharmacy you can verify on the GPhC register, sourcing medicines only against a genuine prescription following clinical assessment, and being wary of sellers who approach via social media or offer prices that seem inexplicably low, these are the checks that matter. You can report a suspect seller directly via the MHRA's Yellow Card scheme. Price matters, and if you are starting out on the lowest dose it is also worth reviewing what Wegovy 0.25 mg costs so you have a reliable baseline for comparing providers. But for a prescription-only medicine, the cheapest listing does not answer the question you actually need answered, which is whether you are getting something real, safe, and right for you. That is a clinical question, and it starts with a free consultation.